Kyle Faget Authors Article on ‘Compliance Considerations for Entities Providing Hybrid Clinical Trial Services’
28 April 2022
Journal of Health Care Compliance
Foley & Lardner LLP Partner Kyle Faget authored the article, “Compliance Considerations for Entities Providing Hybrid Clinical Trial Services,” for the March-April 2022 issue of the Journal of Health Care Compliance. In the article, she discusses how clinical trials are leveraging telehealth, the new business model of hybrid clinical trial services, and compliance considerations that should be addressed to enter the market safely.
People
Related News
06 February 2025
In the News
Vanessa Miller Assesses Panama Canal Discourse
Foley & Lardner LLP partner Vanessa Miller commented in SupplyChainBrain article, "The Fight for Control of the Panama Canal," lending important context to the recent headlines over the important waterway.
06 February 2025
In the News
Gregory Husisian Weighs in on Suspension of De Minimis Trade Exemption
Foley & Lardner LLP partner Gregory Husisian offered context on President Trump's recent trade actions on China in The Wall Street Journal article, "Why Trump Is Closing a Trade Exemption for China."
04 February 2025
In the News
Andrew Wronski on Tariff Fluidity – 'Keep on top of the issues'
Foley & Lardner LLP partner Andrew Wronski assessed the evolving shift in U.S. trade policy in the Milwaukee Business Journal article, "Trump tariffs won't disappear — so how should Wisconsin businesses prepare?"